Status:
TERMINATED
Validation of a Walk-Time Limit Test (WTLT) Derived from the 6-Minute Walk Test (6-MWT) in Patients with Chronic Cardiovascular or Respiratory Diseases
Lead Sponsor:
University Hospital, Brest
Conditions:
Chronic Obstructive Pulmonary Disease
Cardiovascular Insufficiency
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Many exercise tests are commonly used to evaluate the changes of exercise tolerance following rehabilitation programs in patients with chronic respiratory diseases. Among the tests (6-MWT, incrementa...
Detailed Description
Each patient will perform 4 visits over a period of 4-week. Fifty subjects with COPD and fifty subjects with heart failure will be recruited for the same protocol. During the first visit, the subject...
Eligibility Criteria
Inclusion
- Chronic Respiratory Disease Group:
- Diagnosis of COPD with FEV1 corresponding to stages GOLD II or III (50-80% predicted or 30-50% predicted, respectively).
- Patient's agreement
- Being older than 18
- Stable treatment for 3 months
- Subjects affiliated with social security
- Group cardiovascular diseases:
- Diagnosis of heart failure or stable coronary artery disease with NYHA Class II stage.
- Patient's agreement
- Being older than 18
- Stable treatment for 3 months
- Subjects affiliated with social security
Exclusion
- Any medical contraindications to the practice of a suitable physical activity
- Presence of muscle, joint and / or neurological comorbidities affecting motor skills and test performance.
- Refusal of the patient
- Subject under guardianship or curatorship
- Subject aged over 80 at the time of inclusion
- Realization of a rehabilitation program during the study period
- Subject under resting oxygen therapy
- Diagnosis of heart failure, coronary artery disease or any cardiovascular pathology that required surgery.
- Diagnosis of an associated chronic respiratory disease, such as asthma, pulmonary arterial hypertension or interstitial lung disease.
Key Trial Info
Start Date :
February 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04086953
Start Date
February 20 2020
End Date
January 31 2024
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Brest
Brest, France, France, 29200